ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2015
Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.
G Villa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it